Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Elevance Health Inc., 3 years.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
26.6% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Elevance Health Inc. May 14, 202595.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 13, 2026 | Elevance Health Inc. | Grant or award | +563 | — | — |
| Feb 18, 2026 | Immunocore Holdings plc | Open-market sale | −11,474 | $32.35 | $371,184 |
| Feb 17, 2026 | Immunocore Holdings plc | Option exercise | +23,817 | — | — |
| May 14, 2025 | Elevance Health Inc. | Grant or award | +601 | — | — |
| May 15, 2024 | Elevance Health Inc. | Grant or award | +388 | — | — |
| May 10, 2023 | Elevance Health Inc. | Grant or award | +457 | — | — |
Questions about Bahija Jallal
What boards is Bahija Jallal on?
Bahija Jallal sits on the boards of ArriVent BioPharma Inc., Elevance Health Inc. and Immunocore Holdings plc.
What company is Bahija Jallal the CEO of?
Bahija Jallal has been CHIEF EXECUTIVE OFFICER of Immunocore Holdings plc since January 2024.
How long has Bahija Jallal served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.